SOUTH KOREA – Samsung Biologics has completed the US$2.3 billion acquisition of Biogen’s stake in the Samsung Bioepis joint venture. Samsung Biologics signed a stake acquisition agreement in January of…
Read MoreSamsung Biologics shells US$2.3 bln to complete acquisition of Samsung Bioepis
